Citation Impact
Citing Papers
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
GPCR activation mechanisms across classes and macro/microscales
2021
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes
2005
The Mechanosensitive Ion Channel Piezo Inhibits Axon Regeneration
2019 StandoutNobel
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
2016
Cholesterol, sphingolipids, and glycolipids: What do we know about their role in raft-like membranes?
2014
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
2017 NatureNobel
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Cell-based and virtual fragment screening for adrenergic α2C receptor agonists
2015
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
How Ligands Illuminate GPCR Molecular Pharmacology
2017
The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer
2013
Molecular Dynamics Simulation for All
2018 Standout
Challenges and opportunities for non-antibody scaffold drugs
2015
Biochemistry of Soluble Guanylate Cyclase
2008
Nitric oxide-sensitive guanylyl cyclase: structure and regulation
2004
Signalling via cGMP: Lessons from Drosophila
2005
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
2012 StandoutNatureNobel
Role of Detergents in Conformational Exchange of a G Protein-coupled Receptor
2012 StandoutNobel
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord
2006
New paradigms in GPCR drug discovery
2015
Breaking the bottleneck: Eukaryotic membrane protein expression for high-resolution structural studies
2007
Evaluation of the Pichia pastoris expression system for the production of GPCRs for structural analysis
2011
Structures of membrane proteins
2010 StandoutNobel
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Structure determination of the seven-helix transmembrane receptor sensory rhodopsin II by solution NMR spectroscopy
2010
Large-scale production of functional membrane proteins
2008
Membrane mimetic systems in CryoEM: keeping membrane proteins in their native environment
2019 StandoutNobel
Nitric oxide signaling: no longer simply on or off
2006
The therapeutic potential of carbon monoxide
2010 Standout
Are GPCRs Still a Source of New Targets?
2013
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
2005
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice
2009 StandoutNobel
Species differences in the localization of cGMP‐producing and NO‐responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry
2004
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists
2016
Crystal Structures of Protein-Bound Cyclic Peptides
2019
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field
2015 Standout
Regulation of Nitric Oxide-Sensitive Guanylyl Cyclase
2003
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
2017
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists
2017 StandoutNobel
Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
2018 Standout
Determination of solution structures of proteins up to 40 kDa using CS-Rosetta with sparse NMR data from deuterated samples
2012 StandoutNobel
NO-Independent, Haem-Dependent Soluble Guanylate Cyclase Stimulators
2008
Works of Markus Koglin being referenced
Biophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design
2013
Erratum: Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
2017
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
2017
Developmental Changes of Nitric Oxide-Sensitive Guanylyl Cyclase Expression in Pulmonary Arteries
2001
Nitric Oxide Activates the β2 Subunit of Soluble Guanylyl Cyclase in the Absence of a Second Subunit
2001
Therapeutic antibodies directed at G protein-coupled receptors
2010
Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727
2018 Nature
Extra-helical binding site of a glucagon receptor antagonist
2016 Nature
Characterization of 16 human G protein-coupled receptors expressed in baculovirus-infected insect cells
2005
A Functional Domain of the α1 Subunit of Soluble Guanylyl Cyclase Is Necessary for Activation of the Enzyme by Nitric Oxide and YC-1 but Is Not Involved in Heme Binding
2003
BAY 41-2272 Activates Two Isoforms of Nitric Oxide- Sensitive Guanylyl Cyclase
2002
Biliverdin IX is an endogenous inhibitor of soluble guanylyl cyclase
2002
Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment
2013